• BX Home
  • Multiple Sclerosis: News [Page 7]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

MULTIPLE SCLEROSIS

Multiple sclerosis (MS) is an autoimmune condition that attacks the central nervous system. This topic tracks information on multiple sclerosis treatments and the financial impact on companies researching and developing new drugs to fight this terrible disease.

Multiple Sclerosis is part of Business Exchange, suggested by Steve McCarthy. This topic contains 967 news and 242 blog items. Read updated news, blogs, and resources about Multiple Sclerosis. Find user-submitted articles and reactions on Multiple Sclerosis from like-minded professionals.

News

Please add new articles to this topic

Teva Pharmaceutical offers $6.8 billion for Cephalonmore

warning by the Food and Drug Administration over quality-control problems. Sales of Copaxone, used in the treatment of...

Fixes: Helping New Drugs Out of Research's 'Valley of Death'more

Fixes looks at solutions to social problems and why they work. Tags: Drugs (Pharmaceuticals), , Multiple Sclerosis,...

Teva to Present at the Deutsche Bank 36th Annual Health Care Conferenc...more

as well as biologics. Teva's leading innovative product, Copaxone(R), is the number one prescribed treatment for...

Helping New Drugs Out of Research's 'Valley of Death'more

organization called the (M.R.F.) that is working to accelerate the development of a novel treatment for multiple...

UPDATE 2-Teva to buy Cephalon for over $6 bln, tops Valeantmore

Adding Cephalon's pain, sleep and cancer drugs will help Teva reduce its dependence on its big-selling Copaxone...

PrecisionMed Inc. Announces Availability of CSF and Plasma From a Sing...more

PrecisionMed sponsored CSF collection studies: Alzheimer's disease (SAMPLE REGISTRY), Parkinson's disease, elderly...

Teva tops Valeant to buy Cephalonmore

protection. Adding Cephalons pain, sleep and cancer drugs will help Teva reduce its dependence on its big-selling...

Reportlinker Adds Neuroprotection - Drugs, Markets and Companiesmore

traumatic brain injury, spinal cord injury, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic...

Teva to Buy Cephalon for $6.2 Billionmore

competition to its biggest product. The $6.2 billion deal announced today gives Teva, which relies on the multiple...

Phil Keoghan���s ���Amazing��� adventuremore

cross-country cycling trip throughout the U.S., spanning 3,500 miles in 40 days, to raise awareness for multiple...

U.S. Stocks Fall as Drop in Oil Companies Overshadows Bin Ladenmore

8 billion. Buying Cephalon would help Teva offset the revenue it may lose as its top-selling product, the multiple...

Return on Equity at 10-Year High Fails to Lift Stocksmore

Illinois-based Caterpillar Inc., the world���s largest maker of construction equipment, and Biogen Idec Inc.

U.S. Stocks Fall as Valuations Overshadow Bin Laden Deathmore

8 billion. Buying Cephalon would help Teva offset the revenue it may lose as its top-selling product, the multiple...

Yoga and Pilates may help ease some symptoms of multiple sclerosismore

Multiple sclerosis symptoms can take a toll, but staying on a regular exercise regimen may help. Join a on the benefits...

U.S. Stocks Are Little Changed Amid Concern Over Valuationsmore

8 billion. Buying Cephalon would help Teva offset the revenue it may lose as its top-selling product, the multiple...

Teva agrees $6.8bn Cephalon dealmore

Extract not available.

U.S. Stocks Erase Earlier Gains Triggered by Death of Bin Ladenmore

8 billion. Buying Cephalon would help Teva offset the revenue it may lose as its top-selling product, the multiple...

Teva to Buy Cephalon for $6.2 Billion, Topping Valeant Bidmore

buy Cephalon. Acquiring Cephalon will help Teva offset the revenue it may lose as its top-selling product, the multiple...

Return on Equity Hitting 10-Year High Fails to Drive Valuationsmore

Illinois-based Caterpillar Inc., the world���s largest maker of construction equipment, and Biogen Idec Inc.

How Teva, Cephalon comparemore

from generic drugs. But, the company is trying to expand its branded drug offerings, which currently include the...

U.S. Stocks Advance After Obama Says U.S. Has Killed Bin Ladenmore

billion. Buying Cephalon would help Teva offset the revenue it may lose as its top- selling product, the multiple...

UPDATE 3-Teva to buy Cephalon for $6.8 bln, tops Valeantmore

Adding Cephalon's pain, sleep and cancer drugs will help Teva reduce its dependence on its big-selling Copaxone...

Windsor Native Increases Gift to $2 Million, MS Awareness Month Beginsmore

Windsor native Doug Bergeron and his wife Sandra Bergeron announced that they have doubled their commitment to the...

Teva to buy Cephalon for $6.8bnmore

Extract not available.

'Dancing' finale tickets sell for more than $10Kmore

Erase MS Gala in Los Angeles, Friday, April 29, 2011. The event benefits the Nancy Davis Foundation for Multiple...

Top Sources: Multiple Sclerosis

  • St. Petersburg Times
  • Reuters
  • Chicago Tribune
  • Mail Online UK
  • MarketWatch
  • BBC
  • Boston Globe
  • Philadelphia Inquirer
  • BusinessWeek
  • Seattle Times

Most Active Users in this Topic

see all contributors in Multiple Sclerosis

Featured White Papers

Post a Job

Jobs in this Topic

Director Specialty Distribution Multiple Sclerosis Genzyme | Cambridge, MA
Posted: Mar 29
RN/Registered Nurse Clinical Coordinator - Ambulatory Mulitple Sclerosis Center Rush University Medical Center | Chicago, IL
Posted: May 14
Multiple Sclerosis Nurse Educator Quintiles Transnational | Lansing, MI
Posted: May 20
Client in West Virginia Seeking Multiple Neurologist Alliance Recruiting Resources | West Virginia
Posted: May 23
Neurology - Multiple Sclerosis Physician Practicewisemd | Cincinnati, OH
Posted: Mar 30

Report comment contains invalid characters. ()
cancel
Search Cancel